Chemistry and pathobiology of advanced glycation end products.
Schleicher
E D
ED
Department for Internal Medicine, Division of Endocrinology, Metabolism and Pathobiochemistry, University of Tübingen, Germany. enschlei@med.uni-tuebingen.de
Bierhaus
A
A
Häring
H U
HU
Nawroth
P P
PP
Lehmann
R
R
D000375:Aging / Q000378:metabolism; D003847:Deoxyglucose / Q000031:analogs & derivatives* / Q000378:metabolism; D003920:Diabetes Mellitus / Q000378:metabolism; D003928:Diabetic Nephropathies / Q000378:metabolism; D005786:Gene Expression Regulation; D005947:Glucose / Q000378:metabolism; D017127:Glycation End Products, Advanced / Q000737:chemistry / Q000378:metabolism*; D006023:Glycoproteins / Q000378:metabolism; D006031:Glycosylation; D006037:Glyoxal / Q000378:metabolism; D006801:Humans; D007678:Kidney Glomerulus / Q000378:metabolism; D015227:Lipid Peroxidation; D016328:NF-kappa B / Q000378:metabolism; D018384:Oxidative Stress; D011765:Pyruvaldehyde / Q000378:metabolism; D017382:Reactive Oxygen Species
D017127:Glycation End Products, Advanced; D006023:Glycoproteins; D016328:NF-kappa B; D017382:Reactive Oxygen Species; C060458:3-deoxyglucose; D006037:Glyoxal; D011765:Pyruvaldehyde; D003847:Deoxyglucose; D005947:Glucose